Trial site
Tianjin People's Hospital
- 31running trials
- 8closed trials
The trials here
What the 40 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia3 trials
- Chronic kidney disease3 trials
- Coronary artery disease3 trials
- Alzheimer disease2 trials
- Chronic rhinosinusitis with nasal polyps2 trials
- Colorectal cancer2 trials
- Familial hypercholesterolaemia2 trials
- Follicular lymphoma2 trials
- Heart failure2 trials
- Immune thrombocytopenia (ITP)2 trials
- Migraine2 trials
- Multiple myeloma2 trials
- and 14 more
- Phase
- Phase 321 trials
- Phase 29 trials
- Phase 14 trials
- Phase 2/33 trials
- Phase 42 trials
- Status
- Recruiting17 trials
- Not yet recruiting10 trials
- Completed8 trials
- Active, not recruiting4 trials
- Suspended1 trial
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.4 trials
- Eli Lilly and Company4 trials
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.3 trials
- Bayer2 trials
- Beijing InnoCare Pharma Tech Co., Ltd.2 trials
- and 22 more
Running trials
Not yet recruiting
Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults
Recruiting
Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults
Not yet recruiting
Recruiting
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
Recruiting
Recruiting
A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
Recruiting
Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A)
Recruiting
Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)
Recruiting
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
Recruiting
A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia
Recruiting
Recruiting
Recruiting
Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia3 recruiting
- Alzheimer disease2 recruiting
- Coronary artery disease2 recruiting
- Immune thrombocytopenia (ITP)2 recruiting
- Migraine2 recruiting
- Multiple myeloma2 recruiting
- Peripheral artery disease2 recruiting
- Thyroid cancer2 recruiting
- Ulcerative colitis2 recruiting
- Chronic kidney disease1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Crohn's disease1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Follicular lymphoma1 recruiting
- Heart failure1 recruiting
- Myelodysplastic syndromes1 recruiting
- Neuroendocrine tumours1 recruiting
Closed trials
Completed
Completed
A Study of Daridorexant in Chinese Patients With Insomnia Disorder
Completed
AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026